Navigation Links
Harnessing genomic research

Regeneration of spinal nerve cells, a new way to personalise breast cancer treatment, rapid near-patient diagnosis of meningitis, MRSA and Chlamydia and effective vaccines to protect against salmonella are all important applications to have benefited from a £30M research programme built around harnessing knowledge of the human and other genomes.

A key feature of this LINK Applied Genomics Programme has been effective collaboration between industry and academia aimed at accelerating the application of knowledge of genomics in biomedicine and healthcare.

The programme funded 21 projects covering diverse research areas. Highlights from the programme include:

Nerve tissue regeneration- During spinal cord injury the nerves that transmit information between the brain and the body are injured and fail to regrow. The loss of this communication leads to paralysis and loss of sensation. Scientists at King's College London and Oxford BioMedica are investigating a receptor which allows nerve cells to reform severed connections. Identifying the genes that contribute to this regeneration will allow the team to understand why damaged nerve cells are unable to repair themselves. The work could lead to ways of stimulating nerves to regrow and repair damaged connections.

Personalised cancer treatment- A large number of cancers are linked to mutations in a specific gene or biological pathway. Researchers from KuDOS pharmaceuticals, Imperial College London and the Gurdon Institute, Cambridge are exploring ways to identify molecular signatures resulting from the loss of specific gene function in breast cancers that will correlate with susceptibility to a new anti-cancer drug being developed by KuDOS. The drug involved has the potential to kill tumour cells without affecting normal cells, so avoiding the side effects of hair-loss and nausea that often result from existing therapies. The genes and biological pathway under investigation are in volved in hereditary breast and ovarian cancers and have also been linked to other types of cancers.

Rapid diagnosis of infectious diseases?/B> Scientists at the Universities of Bath and Glasgow, with colleagues from Stobhill Hospital and Atlas Genetics Ltd are miniaturising established molecular techniques and combining them with novel assays to develop a hand-held 'chip' that will allow doctors to identify specific bacteria in patient samples. In the future this chip could be used to for rapid diagnosis of dangerous diseases such as MRSA infection and bacterial meningitis, where fast confirmation is critical, or for potentially catastrophic but widespread and non-symptomatic infections such as that caused by Chlamydia.

Vaccine against salmonella?/B> A team investigating the microbial genes important for the survival and growth of the salmonella pathogen during infection is using this knowledge to generate mutant bacterial strains that may be useful as vaccines. Experiments under way have shown several mutant bacterial strains to be highly effective as vaccines. In comparative studies one of the new strains had similar efficacy to that conferred by the current vaccine 'gold-standard' strain. Scientists from the Universities of Cambridge, Newcastle and Oxford and University College London have been working with their partner Arrow Therapeutics to combat this costly and dangerous livestock and human disease.

The highlights of the research programme are being presented to Parliamentarians and business leaders at a reception in London on the evening of 10 November. The programme was sponsored by the Biotechnology and Biological Sciences Research Council (BBSRC), the Department of Trade and Industry (DTI) and the Medical Research Council (MRC).


'"/>

Source:Biotechnology and Biological Sciences Research Council


Related biology news :

1. Harnessing microbes, one by one, to build a better nanoworld
2. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
3. Enzyme shown to help protect genomic stability
4. New comparative toxicogenomics database
5. Scientists document complex genomic events leading to the birth of new genes
6. Study of genomic DNA leads to new advances in cancer diagnostics
7. Measuring the impact of post-genomics on Mediterranean populations
8. Genrate: a generative model that finds and scores new genes and exons in genomic microarray data
9. PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information
10. Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis
11. Enlisting genomics to understand flu evolution
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... ... quality, regulatory and technical consulting, provides a free webinar on Performing ... July 13, 2016 at 12pm CT at no charge. , Incomplete investigations are ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
(Date:6/22/2016)... June 22, 2016 Cell Applications, Inc. ... them to produce up to one billion human ... within one week. These high-quality, consistent stem cells ... cells and spend more time doing meaningful, relevant ... proprietary, high-volume manufacturing process that produces affordable, reliable ...
(Date:6/22/2016)... YORK , June 22, 2016  According ... growing next generation sequencing (NGS) market include significant ... of smaller sequencers.  More accessible and affordable sequencers, ... to growing demand for consumables including sample prep ... The Market for Sample Preparation for Next Generation ...
Breaking Biology Technology: